How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey

Maria Grazia Bongiorni; Germanas Marinskis; Gregory Y H Lip; Jesper Hastrup Svendsen; Dan Dobreanu; Carina Blomström-Lundqvist; Scientific Initiative Committee, European Heart Rhythm Association

doi:10.1093/europace/eus350

How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey

Europace. 2012 Nov;14(11):1666-9. doi: 10.1093/europace/eus350.

Authors

Maria Grazia Bongiorni¹, Germanas Marinskis, Gregory Y H Lip, Jesper Hastrup Svendsen, Dan Dobreanu, Carina Blomström-Lundqvist; Scientific Initiative Committee, European Heart Rhythm Association

Collaborators

Scientific Initiative Committee, European Heart Rhythm Association:
Carina Blomstrom-Lundqvist, Philippe Mabo, Maria Grazia Bongiorni, Nikolaos Dagres, Dan Dobreanu, Isabel van Gelder, Thorsten Lewalter, Gregory Y H Lip, Germanas Marinskis, Laurent Pison, Alessandro Proclemer, Jesper Hastrup Svendsen

Affiliation

¹ Second Cardiology Department, University Hospital of Pisa, Pisa, Italy. [email protected]

PMID: 23104858
DOI: 10.1093/europace/eus350

Abstract

The purpose of our survey is to analyse the clinical approach used to prevent and treat cardiovascular implantable electronic device (CIED) infections in Europe. The survey involves high-volume implanting centres. According to the survey the incidence of CIED infections shows a slight decrease in most centres and is substantially under 2% in the majority of centres interviewed. However, there are still differences in terms of prophylactic antibiotic therapy: 8.9% of the centres administer oxacillin as preoperative treatment, 4.4% of them do not give any antibiotic therapy, all centres use some kind of skin antisepsis, but only 42.2% use chlorhexidine. In case of local infection, 43.5% of centres perform lead extraction as first approach. In the case of systemic infection or evidence of lead or valvular endocarditis, 95% of centres treat these conditions by extracting the leads, which indicates that the adherence to the lead extraction guidelines is quite good.

Publication types

Multicenter Study

MeSH terms

Anti-Bacterial Agents / administration & dosage
Anti-Infective Agents, Local / administration & dosage
Antibiotic Prophylaxis
Antisepsis
Cardiac Resynchronization Therapy / adverse effects*
Cardiac Resynchronization Therapy Devices / adverse effects*
Chlorhexidine / administration & dosage
Defibrillators, Implantable / adverse effects
Device Removal
Electric Countershock / adverse effects*
Electric Countershock / instrumentation
Europe / epidemiology
Guideline Adherence
Health Care Surveys
Hospitals, High-Volume
Humans
Incidence
Infection Control* / methods
Infection Control* / statistics & numerical data
Practice Guidelines as Topic
Practice Patterns, Physicians'* / statistics & numerical data
Prosthesis Design
Prosthesis-Related Infections* / diagnosis
Prosthesis-Related Infections* / epidemiology
Prosthesis-Related Infections* / microbiology
Prosthesis-Related Infections* / prevention & control
Prosthesis-Related Infections* / therapy
Skin / drug effects
Skin / microbiology

Substances

Anti-Bacterial Agents
Anti-Infective Agents, Local
Chlorhexidine